RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Sectoral Asset Management
S

Sectoral Asset Management portfolio

Sectoral Asset Management has 3 portfolio companies on record at Recent Funding.

Website: sectoral.com.
Type: Crossover fund.
Portfolio on Recent Funding: 3.
Deals, last 12 months: 0.
Rounds led: 3 of 4.
Capital in their rounds: $302M.
Latest deal: Phagenesis · Mar 4, 2024.
About this page

It is a crossover fund based in Montreal, CA, founded in 2000. It led 3 of the 4 rounds it joined. Its most recent investment on record is Phagenesis's $42M Series B+ round in March 2024, which it led, alongside EQT Life Sciences, Aphelion Capital, British Patient Capital and 1 other. By category, its portfolio leans toward Health and bio (3) and Commerce and retail (1). It has co-invested with OrbiMed, EQT Life Sciences and Mass General Brigham Ventures, most often OrbiMed (3 rounds).

About Sectoral Asset Management

Firm type: Crossover fund.
Headquarters: Montreal, CA.
Founded: 2000.
Stages: Series B, Late Stage.
Sectors: Biotech, Digital Health, Healthtech, Medical Devices.
Check size: $5M.

What Sectoral Asset Management invests in

Sectoral Asset Management recent investments

CompanyRoundDateAlongside
PPhagenesisSeries B+ · $42M · leadEQT Life Sciences (lead), Aphelion Capital, British Patient Capital +1
NNoctrix HealthSeries B+ · $40M · leadAngelini Ventures, Treo Ventures, OrbiMed +2
AAmolyt PharmaSeries B+ · $140MMass General Brigham Ventures, Intermediate Capital Group (lead), Pontifax +6
AAmolyt PharmaSeries B+ · $80M · leadSham, EQT Life Sciences, Mass General Brigham Ventures +6

How Sectoral Asset Management invests

StageDealsCapital in rounds
Series B+ 4 100%$302M
YearDealsCapital in rounds
2021 1 25%$80M
2023 1 25%$140M
2024 2 50%$82M

Sectoral Asset Management portfolio companies

CompanyRound with Sectoral Asset ManagementTotal raisedLatest raise
PPhagenesis
Health and bio
Series B+ · $42M · lead$51.31MSep 1, 2024
Series B+
NNoctrix Health
Health and bio
Series B+ · $40M · lead$73.5MSep 2, 2025
round
AAmolyt Pharma
Health and bio
Series B+ · $140M$294MJan 6, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 4 rounds on Recent Funding that name Sectoral Asset Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Sectoral Asset Management, which is a subset of its real portfolio. API: /api/v1/investors/sectoral-asset-management (get a free API key). More: the most active VC firms and new venture capital funds.